EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Predicting prognosis in ANCA-associated vasculitis with kidney involvement

Christian Maalouli, Selda Aydin, Alix Collard, Jean-Francois Cambier, Agnes Dejardin, Benoit Georges, Gaelle Gillerot, Benedicte Vanderperren, Ann-Karolien Vandooren, Michel Jadoul iD, Johann Morelle iD, Nathalie Demoulin iD und 1 weitere

Clinical Kidney Journal · 01.09.2025 · 18 (9)

DOI: 10.1093/ckj/sfaf268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 26.08.2025. Verfasst von Christian Maalouli und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Centre Hospitaliser de Wallonie Picarde, Tournai, Belgium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The ANCA Renal Risk Score was updated in 2023 to the ANCA Kidney Risk Score (AKRiS) to improve clinicopathological prognostication in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and kidney involvement. Our study aimed to assess whether incorporating recently identified predictors of kidney survival in AAV could further refine the prognostic accuracy of AKRiS in our multicentric cohort.

Methods

We retrospectively reviewed all incident AAV with kidney biopsy from 2005 to 2020. Cox regression analysis examined factors [AKRiS, dialysis within 4 weeks, urine protein–creatinine ratio (UPCR) and hematuria at baseline, C3 deposits, renal arteritis on biopsy, estimated glomerular filtration rate (eGFR), UPCR and hematuria after induction] associated with kidney failure. These factors in combination with AKRiS were analyzed using the area under the receiver operating characteristic curve (AUROC) for prediction of kidney failure.

Results

The cohort included 115 patients (age 64 years, 55% male, 57% myeloperoxidase-ANCA, baseline creatinine 3.6 mg/dL, eGFR 16 mL/min/1.73 m2), with 34 (30%) dialysed within 4 weeks. During a median 6.4-year follow-up, 39 (34%) patients progressed to kidney failure, and 13 (11%) died. Cox analysis identified AKRiS, dialysis within 4 weeks, C3 deposits, renal arteritis on biopsy, lower eGFR after induction and higher UPCR after induction as unadjusted risk factors for kidney failure. After adjusting for AKRiS, dialysis within 4 weeks [hazard ratio (HR) 6.20 (95% confidence interval 2.76 to 13.95), P ≤ .001], eGFR after induction [HR 0.94 (0.89 to 0.99), P = .03] and UPCR after induction [HR 1.62 (1.02 to 2.58), P = .04] remained significantly associated with kidney outcome. The AUROC for kidney failure prediction was 0.77 for AKRiS, increasing to 0.82, 0.80 and 0.79 when adding dialysis within 4 weeks, eGFR and UPCR after induction, respectively.

Conclusion

Dialysis within 4 weeks, eGFR after induction and UPCR after induction are able to predict long-term kidney outcome in AAV patients. Adjusting AKRiS for these variables modestly enhances its predictive power. We propose using them as placeholder endpoints for kidney failure in future studies.

Schlagwörter

Stichwörter der Autor:innen

AKRiSANCA Renal Risk Scorepauci-immune necrotizing glomerulonephritis

Autor:innen und Institutionen

  • Division of Nephrology, Centre Hospitaliser de Wallonie Picarde, Tournai, Belgium.
  • Department of Pathology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
  • Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium.
  • Statistical Support Unit, Cliniques universitaires Saint-Luc, Brussels, Belgium.
  • Department of Nephrology, Grand Hôpital de Charleroi, Gilly, Belgium.
  • Department of Nephrology, Cliniques de l'Europe, Brussels, Belgium.

ORCID-Profile: Michel Jadoul, Johann Morelle, Nathalie Demoulin

Zitieren

APA

Maalouli, C., Aydin, S., Collard, A., Cambier, J. F., Dejardin, A., Georges, B., Gillerot, G., Vanderperren, B., Vandooren, A. K., Jadoul, M., Morelle, J., Demoulin, N., & UCLouvain Kidney Disease Network (2025). Predicting prognosis in ANCA-associated vasculitis with kidney involvement. Clinical Kidney Journal, 18(9). https://doi.org/10.1093/ckj/sfaf268

Vancouver

Maalouli C, Aydin S, Collard A, Cambier JF, Dejardin A, Georges B, et al. Predicting prognosis in ANCA-associated vasculitis with kidney involvement. Clinical Kidney Journal. 2025;18(9). doi:10.1093/ckj/sfaf268

BibTeX
@article{Maalouli2025,
  author = {Maalouli, Christian and Aydin, Selda and Collard, Alix and Cambier, Jean-Francois and Dejardin, Agnes and Georges, Benoit and Gillerot, Gaelle and Vanderperren, Benedicte and Vandooren, Ann-Karolien and Jadoul, Michel and Morelle, Johann and Demoulin, Nathalie and UCLouvain Kidney Disease Network, UCLouvain Kidney Disease Network},
  title = {Predicting prognosis in ANCA-associated vasculitis with kidney involvement},
  journal = {Clinical Kidney Journal},
  year = {2025},
  volume = {18},
  number = {9},
  doi = {10.1093/ckj/sfaf268}
}
Kostenlos starten →